Episode 41 Kratom: Friend or Foe ToxNow

In this episode we talk to Ed Boyer about Kratom, pharmacology, legal status, and discuss recent reports of adverse effects.



* Boyer et al Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth)

* FDA response to Kratom

* Bradford Hill Criteria



Take Home Points:



* Kratom is an opioid agonist

* Patients should not mix Kratom with other substances

* Patients at risk of seizures should not use Kratom

* Kratom will not show up on a typical urine drug screen